Published in Langenbecks Arch Chir on December 22, 1976
Advantages of collagen based biological dressings in the management of superficial and superficial partial thickness burns in children. Ann Burns Fire Disasters (2013) 0.82
In vivo performance of chitosan/soy-based membranes as wound-dressing devices for acute skin wounds. Tissue Eng Part A (2013) 0.79
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J Infect Dis (1975) 4.36
Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet (1993) 4.12
Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect Immun (1996) 3.51
Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa. Infect Immun (1978) 3.15
Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model. Infect Immun (1982) 2.48
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors. Can J Microbiol (1979) 2.30
Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol (2010) 2.22
BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel. Br J Dermatol (2013) 2.17
Flagella of Salmonella typhimurium are a virulence factor in infected C57BL/6J mice. Infect Immun (1984) 2.15
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies. Infect Immun (1982) 2.01
Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues. Appl Microbiol (1972) 1.89
Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues. J Infect Dis (1977) 1.84
Burn wounds: microbiology, local host defenses, and current therapy. CRC Crit Rev Clin Lab Sci (1973) 1.70
Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization. Infect Immun (1982) 1.67
The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend (1995) 1.46
A sequential, prospective analysis of immunologic abnormalities and infection following severe thermal injury. Ann Surg (1978) 1.38
Experience with Candida infections in the burn patient. Arch Surg (1972) 1.38
Sunitinib and other targeted therapies for renal cell carcinoma. Br J Cancer (2011) 1.27
Epidemiology of Pseudomonas aeruginosa in a burns hospital: surveillance by a combined typing system. Appl Microbiol (1972) 1.27
Growth of Pseudomonas aeruginosa in normal and burned skin extract: role of extracellular proteases. Infect Immun (1979) 1.26
Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect Immun (1995) 1.20
Platelet accumulation observed by electron microscopy in the early phase of renal allotransplant rejection. Nature (1968) 1.19
Control of surface wound infection: skin versus synthetic grafts. Appl Microbiol (1973) 1.19
Epidemiology of pseudomonas aeruginosa in a burn hospital: evaluation of serological, bacteriophage, and pyocin typing methods. Appl Microbiol (1972) 1.17
Effect of Antibiotic and Chemical Dips on the Microflora of Packaged Salad Mix. Appl Microbiol (1960) 1.17
Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg (2010) 1.16
Rat thymic dihydrotestosterone receptor: preparation, location and physiochemical properties. Steroids (1979) 1.12
The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati. Can J Microbiol (1985) 1.12
Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease. Can J Microbiol (1984) 1.10
Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse. J Surg Res (1973) 1.08
Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis. Microbiology (2000) 1.07
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations. J Trauma (1986) 1.07
Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes. Infect Immun (1986) 1.05
Enhanced survival in burned mice treated with antiserum prepared against normal and burned skin. J Trauma (1971) 1.03
Modifications of a Candida albicans biotyping system. J Clin Microbiol (1989) 1.02
Cytotoxicity testing of topical antimicrobial agents on human keratinocytes and fibroblasts for cultured skin grafts. J Burn Care Rehabil (1995) 1.01
Effect of a synthetic dressing formed on a burn wound in rats: a comparison of allografts, collagen sheets, and polyhydroxyethylmethacrylate in the control of wound infection. Appl Microbiol (1974) 0.98
Effect of proteolytic activity on virulence of Candida albicans in burned mice. Infect Immun (1990) 0.96
Evaluation of candida precipitin and agglutinin tests for the diagnosis of systemic candidiasis in burn patients. J Clin Microbiol (1977) 0.95
Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes. Antimicrob Agents Chemother (1995) 0.94
Speciation and amphotericin B sensitivity studies on blood isolates of Candida from burned patients. J Clin Pathol (1973) 0.93
A cognitive-behavioural, group-based intervention for social anxiety in schizophrenia. Aust N Z J Psychiatry (2000) 0.93
Differential localization of membrane receptor chemotaxis proteins in the Caulobacter predivisional cell. J Mol Biol (1986) 0.91
The participation of platelets in the rejection of dog kidney allotransplants: hematologic and electron microscopic studies. Transplant Proc (1969) 0.91
Experimental studies of the pathogenesis of Pseudomonas aeruginosa infection: evidence for the in-vivo production of a lethal toxin. J Med Microbiol (1978) 0.91
Localized and systemic hypersensitivity reactions to human seminal fluid. Ann Intern Med (1981) 0.91
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: effect of treatment with protease inhibitors. Rev Infect Dis (1984) 0.88
Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing. J Trauma (1981) 0.87
Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds. Antimicrob Agents Chemother (1993) 0.86
Correlation of segmental carpal tunnel pressures with changes in hand and wrist positions in patients with carpal tunnel syndrome and controls. J Hand Surg Br (1998) 0.86
Plasma proteolytic activity following burns. J Trauma (1988) 0.86
Characterization of Candida isolates from pediatric burn patients. J Clin Microbiol (1988) 0.86
Secondary traumatization in children of Vietnam veterans. Hosp Community Psychiatry (1985) 0.86
Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection. Burns (1996) 0.85
A new model for studying the development of human hypertrophic burn scar formation. J Burn Care Rehabil (1987) 0.84
Antigenic components of normal and burned mouse skin. Experientia (1970) 0.84
A clinical study of antimicrobial agents delivered to burn wounds from a drug-loaded synthetic dressing. J Trauma (1982) 0.84
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin. Am J Med (1984) 0.84
Then and now: studies using a burned mouse model reflect trends in burn research over the past 25 years. Burns (1999) 0.83
Rat thymic estrogen receptor--I. Preparation, location and physiochemical properties. J Steroid Biochem (1979) 0.83
The burned child: a neglected area of psychiatry. Am J Psychiatry (1971) 0.83
Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. Plast Reconstr Surg (1993) 0.82
Biochemical examination of sera during systemic Candida infection in mice. Infect Immun (1978) 0.82
Delivery of the topical antimicrobial agents silver sulfadiazine, gentamicin and nystatin to infected burn wounds in rats from preloaded synthetic dressings. Trans Am Soc Artif Intern Organs (1980) 0.82
Circular organization of the DNA synthetic pathway in Caulobacter crescentus. J Bacteriol (1982) 0.82
The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Oncogene (1996) 0.82
Comparative evaluation of the Candida agglutinin test, precipitin test, and germ tube dispersion test in the diagnosis of candidiasis. J Clin Microbiol (1976) 0.82
Components of the increased circulating proteolytic activity in pediatric burn patients. J Trauma (1992) 0.81
Release of estradiol from fetal bovine serum by rat thymus, spleen, kidney, lung and lung macrophage cultures. Endocrinology (1982) 0.81
Immunologic sequelae of thermal injury. I. Frequency and relationship of epithelial antibodies to extent of burn. Clin Immunol Immunopathol (1976) 0.81
Using bevacizumab to treat metastatic cancer: UK consensus guidelines. Br J Hosp Med (Lond) (2010) 0.81
Factors in prison suicide: one year study in Texas. J Forensic Sci (2001) 0.81
Experience with amphotericin-B in the treatment of systmeic candidiasis in burn patients. Am J Surg (1977) 0.81
The migration of human platelets in vitro. Thromb Diath Haemorrh (1973) 0.80
Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition. Infect Immun (1994) 0.80
Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis. Med Oncol Tumor Pharmacother (1986) 0.80
Rat thymic estrogen receptor--II. Physiological properties. J Steroid Biochem (1979) 0.79
Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice. APMIS (1993) 0.79
Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors. Int J Cancer (1987) 0.79
Characterization and biological activity of the monocytosis-producing agent of Listeria monocytogenes. J Bacteriol (1969) 0.79
Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances. Alcohol Clin Exp Res (1995) 0.79
Effective management of microbial contamination in cultured skin substitutes after grafting to athymic mice. Wound Repair Regen (2006) 0.78
Salmonella typhimurium virulence in a burned-mouse model. Infect Immun (1989) 0.78
Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns. Antibiot Chemother (1971) (1987) 0.78
Effect of challenge with Candida albicans strains with different levels of virulence on plasma proteins in burned mice. Infect Immun (1991) 0.78
Pseudomonas aeruginosa isolates with varying serotype and multiple antibiogram patterns from individual burn patients. J Burn Care Rehabil (1987) 0.78
Antibody activity, contained in a commercial pseudomonas hyperimmune globulin product, against various members of the family Enterobacteriaceae. J Burn Care Rehabil (1988) 0.78
Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second-degree burns. J Burn Care Rehabil (1987) 0.78
Urgent treatment of patients with metastatic melanoma using Braf inhibitors in the absence of Braf mutation status. Ann Oncol (2013) 0.78
Methionine accumulation in villi isolated from maturing rat intestine. J Physiol (1974) 0.78
Antimicrobial resistance. Burns (1999) 0.77